Phospho-RNA pol II CTD (Ser5) Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F0023-20UL

Regular price €189,00 EUR
Regular price Sale price €189,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

POLR2A is a target of interest in many antibody-based workflows. Eukaryotes possess three nuclear DNA-dependent RNA polymerases (RNAPs): RNAP I, RNAP II, and RNAP III. RNAP II, responsible for synthesizing mRNA and many noncoding RNAs (ncRNAs), consists of 12 polypeptides. The largest subunit, Rpb1, harbors the enzyme's catalytic activity and a unique C-terminal domain (CTD) composed of tandem heptad repeats (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7). Depending on the literature source, POLR2A may also be discussed as Phospho-RNA pol II CTD (Ser5) and Phospho RNA polymerase II CTD repeat YSPTSPS (Ser 5).

Reported cellular context includes nucleus, cytoplasm, and chromosome, which can matter when signal is compared across treatments or changing cell states. Following POLR2A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

POLR2A is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, cytoplasm, and chromosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between nucleus, cytoplasm, and chromosome across matched conditions
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • differences between total target abundance and site-specific regulation when modified forms are compared
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for POLR2A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in POLR2A reflect biology rather than handling. When interpreting POLR2A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep POLR2A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
POLR2A
Research Area:
Cell Signaling
Application:
ChIP • ELISA • FCM • IF • WB
Reactivity:
Human • Mouse • Rat
Specificity:
Phospho-RNA pol II CTD (Ser5) Antibody [F13E6] recognizes endogenous levels of total RNA polymerase II CTD repeat YSPTSPS (phospho S5) protein.
Host:
Mouse
Clonality:
Monoclonal
Clone:
F13E6
UniProt:
P24928
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.